Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Enovis CORP Director's Dealing 2022

Mar 1, 2022

31808_dirs_2022-03-01_3e96a387-7c62-40b6-82d2-d914c63e2807.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Colfax CORP (CFX)
CIK: 0001420800
Period of Report: 2022-02-25

Reporting Person: Hix Christopher M (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-25 Common stock, par value $.001 S 2079 $42.18 Disposed 108509 Direct
2022-02-25 Common stock, par value $.001 A 67915 $0.00 Acquired 176424 Direct
2022-02-28 Common stock, par value $.001 S 19330 $40.113 Disposed 157094 Direct
2022-02-28 Common stock, par value $.001 S 11777 $41.179 Disposed 145317 Direct
2022-02-28 Common stock, par value $.001 S 100 $41.72 Disposed 145217 Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs").

F2: Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission ("SEC") on April 1, 2021.

F3: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.69 to $40.67, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.

F4: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.69 to $41.54, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.